Related references
Note: Only part of the references are listed.Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study
A. Henderson et al.
CLINICAL INFECTIOUS DISEASES (2021)
Epidemiology of beta-Lactamase-Producing Pathogens
Karen Bush et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremia
David L. Paterson et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2020)
Multidrug-Resistant Bacterial Infections in US Hospitalized Patients, 2012-2017
John A. Jernigan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Carbapenem-Sparing Strategies for ESBL Producers: When and How
Ilias Karaiskos et al.
ANTIBIOTICS-BASEL (2020)
Beyond Piperacillin-Tazobactam: Cefepime and AAI101 as a Potent β-Lactam - β-Lactamase Inhibitor Combination
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among Enterobacteriaceae Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program
Mariana Castanheira et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
In Vitro Activity of Cefepime-Enmetazobactam against Gram-Negative Isolates Collected from US and European Hospitals during 2014-2015
Ian Morrissey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patients
B. Gutierrez-Gutierrez et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel β-Lactamase Inhibitor Enmetazobactam
Adam Belley et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Ceftolozane/tazobactam for the treatment of complicated intra-abdominal and urinary tract infections: current perspectives and place in therapy
Laura Escola-Verge et al.
INFECTION AND DRUG RESISTANCE (2019)
Antimicrobial resistance surveillance and prediction of Gram-negative bacteria based on antimicrobial consumption in a hospital setting A 15-year retrospective study
Wei Guo et al.
MEDICINE (2019)
Time series analysis of antibacterial usage and bacterial resistance in China: observations from a tertiary hospital from 2014 to 2018
Shuangshuang Zeng et al.
INFECTION AND DRUG RESISTANCE (2019)
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
Alessandro Cassini et al.
LANCET INFECTIOUS DISEASES (2019)
Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections
Beatriz Suay-Garcia et al.
ANTIBIOTICS-BASEL (2019)
Antimicrobial Activity of Ceftolozane-Tazobactam Tested Against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in US Hospitals (2013-2016) as Part of the Surveillance Program: Program to Assess Ceftolozane-Tazobactam Susceptibility
Dee Shortridge et al.
MICROBIAL DRUG RESISTANCE (2018)
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
Eili Y. Klein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Past and Present Perspectives on β-Lactamases
Karen Bush
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance A Randomized Clinical Trial
Patrick N. A. Harris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Carbapenem-Sparing Therapy for Extended-Spectrum β-Lactamase-Producing E coli and Klebsiella pneumoniae Bloodstream Infection The Search Continues
Mary K. Hayden et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study
Elizabeth Temkin et al.
LANCET GLOBAL HEALTH (2018)
Trends and correlation between antibiotic usage and resistance pattern among hospitalized patients at university hospitals in Korea, 2004 to 2012 A nationwide multicenter study
Bongyoung Kim et al.
MEDICINE (2018)
Sparing carbapenem usage
A. Peter R. Wilson
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
The Use of Noncarbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase Infections
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2017)
Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria
Ryan G. D'Angelo et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Characterization of extended-spectrum beta-lactamases and antimicrobial resistance of Klebsiella pneumoniae in intra-abdominal infection isolates in Latin America, 2008-2012. Results of the Study for Monitoring Antimicrobial Resistance Trends
Krystyna M. Kazmierczak et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2015)
Examining the Clinical Effectiveness of Non-Carbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae
Allison M. Gibble et al.
ANTIBIOTICS-BASEL (2015)
Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae
Pierluigi Viale et al.
INFECTIOUS DISEASES AND THERAPY (2015)
The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide
P. Nordmann et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012)
Robert K. Flamm et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Carbapenems: Past, Present, and Future
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Cefepime: a reappraisal in an era of increasing antimicrobial resistance
Andrea Endimiani et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)
Share Paper
